Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia

Oncologist. 2007 Apr;12(4):362-5. doi: 10.1634/theoncologist.12-4-362.
No abstract available

MeSH terms

  • Anemia / complications
  • Anemia / drug therapy*
  • Clinical Trials as Topic
  • Darbepoetin alfa
  • Epoetin Alfa
  • Erythropoietin / adverse effects
  • Erythropoietin / analogs & derivatives*
  • Erythropoietin / therapeutic use
  • Hematinics / adverse effects
  • Hematinics / therapeutic use*
  • Humans
  • Neoplasms / complications
  • Neoplasms / mortality*
  • Recombinant Proteins
  • Safety
  • Survival Analysis

Substances

  • Hematinics
  • Recombinant Proteins
  • epoetin beta
  • Erythropoietin
  • Darbepoetin alfa
  • Epoetin Alfa